Skip to main content

Innovative Perioperative Trial Designs

Edited by:

Associate Professor Mark Edwards, MD, University of Southampton, United Kingdom

Submission Status: Open   |  Submission Deadline: 30 December 2024


Perioperative Medicine invites participating authors to submit to our Collection on Innovative Perioperative Trial Designs. This collection will give an overview of a range of innovative trial designs that are beginning to be adopted into perioperative evidence generation. Readers will be given a comprehensive review of these novel methods, their suitable applications in perioperative research, and key advantages and limitations.

Image credit: © Herjua / Fotolia

About the Collection

Perioperative Medicine invites participating authors to submit to our Collection on Innovative Perioperative Trial Designs. 

Randomised clinical trials are the established gold standard for testing new medical treatments. However, there is increasing recognition that conventional clinical trials are too expensive, and too slow to generate new evidence. The UK’s National Institute for Health & Care Research has encouraged a move towards more efficient and cost-effective trial designs. The potential benefits of developments such as platform trials were highlighted during the Covid pandemic, when multiple treatments were tested in a highly compressed timeframe.

This collection will give an overview of a range of innovative trial designs that are beginning to be adopted into perioperative evidence generation. Expert authors with direct experience will introduce a number of aspects ranging from novel trial structures, methods to enhance large-scale patient recruitment, making the best use of existing datasets, and alternative non-randomised methods. Readers will be given a comprehensive review of these novel methods, their suitable applications in perioperative research, and key advantages and limitations.

Please note that this Collection is exclusively for invited authors.

  1. Remimazolam is a short-acting benzodiazepine newly approved for the induction and maintenance of general anesthesia. Remimazolam emerges as an ideal drug for the neurosurgical population due to its rapid emerg...

    Authors: Jeayoun Kim, Seungwon Lee, Boram Park, Woo Seog Sim, Hyun Joo Ahn, Mi-Hye Park and Ji Seon Jeong
    Citation: Perioperative Medicine 2024 13:56

Submission Guidelines

Back to top

This Collection welcomes submission of research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Innovative Perioperative Trial Designs" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.